openPR Logo
Press release

MedAware Systems Launches Comprehensive Dementia / Alzheimer’s Disease Research Database

12-14-2017 08:38 AM CET | Health & Medicine

Press release from: MedAware Systems, Inc.

MedAware Systems Launches Comprehensive Dementia /

MedAware Systems, Inc. announced today it is launching the world’s most comprehensive database of human clinical trials data on Dementia / Alzheimer’s disease. The database currently contains over 5,000 studies on Dementia and related diseases with more than 30 million data points available for analysis. The Company continuously updates this database as new studies are published.

MedAware Systems’ patent-pending software and process converts published clinical trials into the component data which can then be analyzed using standard statistical analytic techniques.

The database, as well as analytics, are available for licensing by Industry and researchers.

“For the first time, all of the raw data from human clinical trials in the area of Dementia are available in a single database”, says Founder and Chief Science Officer, Dr. Zung Vu Tran, a leading authority on bio-statistics. He adds “We have solved a myriad of problems in collecting, organizing, and standardizing this vast quantity of data. Companies and researchers will now have, at their fingertips, data from thousands of medical research studies on Alzheimer’s disease and other forms of dementia. This will save them years of effort in trying to collect, analyze and continuously update the available science in the field.”

ABOUT MEDAWARE SYSTEMS, INC.

MedAware Systems, Inc. disrupts the health informatics industry by forever changing the way Pharma and medical device companies, physicians, payers and consumers derive usable evidence from published clinical trials research. The Company’s Science of Health Informatics (SOHInfo™) is a Scientific-Data-as-a-Service (SDaaS™) that solves the problem of making the vast and chaotic body of human clinical trials research instantly available and indispensable for understanding the safety and efficacy of medical treatments and devices.

MedAware Systems, Inc.
3400 Industrial Ln. Suite 1B
Broomfield, CO 80020

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release MedAware Systems Launches Comprehensive Dementia / Alzheimer’s Disease Research Database here

News-ID: 859513 • Views: 169

More Releases from MedAware Systems, Inc.

MedAware Systems launches new support system for Clinical Evaluation Reports (CE …
Expanding on the Company’s industry-leading medical research data aggregation and analysis capabilities, MedAware Systems announced today a new application that provides comprehensive information and reporting on the entirety of the published literature for any medical device. It is intended to optimally support companies selling medical devices in Europe, where they are required to develop and maintain a Clinical Evaluation Report (CER) that complies with MEDDEV 2.7.1 revision 4 and the
MedAware Systems Named Top Start Up by The Tech Tribune
MedAware Systems announced today that it has been named a top start up by The Tech Tribune. Companies were evaluated based on four criteria: Revenue potential, Leadership team, Brand/product traction, and Competitive landscape. The Tech Tribune was founded in 2017 and delivers the latest technology news, in-depth technology articles, and insights on the hottest technology startups all over the world. In partnership with Crunchbase, their flagship journalistic endeavor is the
New MedAware Systems Study Published in Pain Physician Journal
MedAware Systems, Inc. announced today that a major research paper entitled Sacroiliac Joint Fusion Methodology - iFuse Implant System® Compared to Screw-type Surgeries: A Systematic Review and Meta-Analysis has been published in the journal Pain Physician. Pain Physician is the official publication of the American Society of Interventional Pain Physicians (ASIPP). It is a peer-reviewed, multi-disciplinary, open access journal written by and directed to an audience of interventional pain physicians, clinicians
MedAware Systems Dementia Research Database Pilot In Use Worldwide
MedAware Systems, Inc. announced today that the pilot of the Company’s Science of Health Informatics (SOHInfo)™ subscription service for Dementia is being used by researchers, scientists, and physicians at the Mayo Clinic, Mount Sinai Health System, Stanford University, The University of Pennsylvania, Florida Atlantic University, Texas A&M Health Science Center, McGill University, and other prominent research institutions. This comprehensive dementia research data application is also being piloted by scientists at

All 5 Releases


More Releases for Dementia

12-11-2018 | Health & Medicine
DST
New App detects dementia risks early
• The App is certified as a Medical Device. • Early stages are reliably detected, before the brain damage becomes irreversible. • Sensitivity above 96%, significantly higher than with the established tests (e.g., MMSE 71%). • Now available for free during pre-launch. Dementia is a rapidly increasing social problem of a rapidly aging society. Because until today there is no effective therapy for advanced stages of dementia. Therefore, effective screening tests are needed to detect early stages
2nd International Conference on Dementia and Dementia Care
Breakthrough in Dementia Research and Care Event Name: 2nd International Conference on Dementia and Dementia Care (Dementia 2019) Theme: Breakthrough in Dementia Research and Care Aim and Scope: Dementia is an umbrella term used to describe a set of symptoms that occur when the brain is affected by disease. There’s currently no cure and no treatment that slows or stops its progression, but there are things you can do to help reduce the
11th International Conference on Vascular Dementia
Can We Cure Dementia, Vascular Dementia and Alzheimer's disease? It’s our pleasure to invite all the participants from all over the world to attend the 11th International Conference on Vascular Dementia which is held during February 15-16, 2019 Amsterdam| Netherlands. Vascular Dementia conference will assemble illustrious speakers, Researchers, Nobel laureates, Neurologists, and Neuroscience researchers from both academic and health care professionals will join this event to discuss their views and research. The
2nd International conference on Dementia and Dementia Care
Breakthrough in Dementia Research and Care Event Name: 2nd International Conference on Dementia and Dementia Care (Dementia 2019) Theme: Breakthrough in Dementia Research and Care Aim and Scope: Dementia is an umbrella term used to describe a set of symptoms that occur when the brain is affected by disease. There’s currently no cure and no treatment that slows or stops its progression, but there are things you can do to help reduce the
Global Alzheimer’s disease, Dementia and Ageing Awareness
Lexis brings in a new spin on conferences by presenting the latest scientific improvements in the fields of Neurology and Neuroscience. Zurich is all set for an amazing event as LEXIS proudly presents the “Global Alzheimers, Dementia and Ageing Awareness” slated on July 17-18, 2019 at Zurich, Switzerland. The theme of the conference is “Global Voice and Awareness on Alzheimers Disease and Dementia Care”. Avenue Roger VAndendriessche, 18 at 1150 BRUSSELS Avenue
Dementia - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Dementia - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dementia - Pipeline Review, H2 2017, provides an overview of the Dementia (Central Nervous System) pipeline landscape. Dementia is the loss of mental functions such as thinking, memory, and reasoning that is severe enough to interfere with